Immuno-Oncology News

July 19, 2019July 19, 2019

Prophylactic anti-TNF Therapy Improves Safety of Immunotherapies, Mouse Study Says

This post was originally published on this siteThis post was originally published on this site Prophylactic anti-TNF therapy improves the safety and, to ... Read more

July 17, 2019July 17, 2019

Transgene Completes Enrollment for Phase 2 Trial of Triple Combo NSCLC Therapy

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Transgene has completed patient enrollment for its Phase ... Read more

July 16, 2019July 16, 2019

FDA Will Review Application Seeking Expansion of Keytruda’s Dosing Schedule

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The U.S. Food and Drug Administration (FDA) has ... Read more

July 12, 2019July 12, 2019

Libtayo Approved in Europe to Treat Metastatic or Advanced Cutaneous Squamous Cell Carcinoma

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Libtayo (cemiplimab) has been conditionally approved to be ... Read more

July 10, 2019July 10, 2019

Trial Will Test Thermal Ablation, Followed By IP-001 Immunotherapy, Against Solid Tumors

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Immunophotonics and Clinical Laserthermia Systems (CLS) are teaming ... Read more

July 9, 2019July 9, 2019

Cancer Vaccine VBI-1901 Well-Tolerated in Recurrent Glioblastoma Patients, Early Phase 1/2a Data Show

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Treatment of recurrent glioblastoma with the investigational cancer ... Read more

July 3, 2019July 3, 2019

Imfinzi Combo Therapy Extends Survival of Advanced SCLC Patients, Phase 3 Trial Shows

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Adding Imfinzi (durvalumab) to standard first-line chemotherapy led ... Read more

July 2, 2019July 2, 2019

DPX-Survivac-Keytruda Trio Shows Promise in DLBCL Patients

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site IMV‘s lead candidate, DPX-Survivac, in combination with Keytruda ... Read more

June 28, 2019June 28, 2019

Complete Remission Induced in B-cell ALL Patients After Single Dose of FasT CAR-19 Therapy, Preliminary Data Show

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site A single infusion of an experimental cell therapy ... Read more

June 26, 2019June 26, 2019

Tislelizumab Produces Promising Anti-Cancer Activity in Advanced Nasopharyngeal Cancer Patients, Preliminary Data Show

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site BeiGene’s investigational anti-PD-1 inhibitor tislelizumab is well-tolerated and ... Read more